Helicobacter pylori infection among patients with liver cirrhosis

Joanna Pogorzelska1, Magda Łapińska, Alicja Kalinowska

  • 1Departments of aInfectious Diseases and Hepatology bPopulation Medicine and Civilization Diseases Prevention, Medical University of Bialystok, Bialystok, Poland.

Insights

Helicobacter pylori infection is more common in patients with liver cirrhosis due to hepatitis C or B viruses than alcoholic cirrhosis. This infection correlates with higher blood ammonia and esophageal varices in cirrhosis patients.

Area of Science:

  • Hepatology and Gastroenterology
  • Microbiology
  • Clinical Medicine

Background:

  • Helicobacter pylori (H. pylori) infection can impact liver function and potentially exacerbate liver cirrhosis.
  • The prevalence and implications of H. pylori in liver cirrhosis patients require further investigation.

Purpose of the Study:

  • To determine the incidence of H. pylori infection in liver cirrhosis patients.
  • To analyze H. pylori prevalence based on cirrhosis etiology and severity (Child-Pugh classification).
  • To assess the relationship between H. pylori infection, esophageal varices, and gastric inflammatory lesions.

Main Methods:

  • A cohort of 147 liver cirrhosis patients was studied, categorized by etiology: hepatitis C virus (HCV), hepatitis B virus (HBV), alcoholic, and primary biliary cirrhosis.
  • H. pylori infection was diagnosed via serum immunoglobulin G antibody detection.
  • Patients were evaluated for esophageal varices and endoscopic gastric lesions.

Main Results:

  • H. pylori infection was detected in 46.9% of the studied liver cirrhosis patients.
  • A significantly higher incidence of H. pylori was observed in postinflammatory liver cirrhosis (HCV/HBV) compared to alcoholic liver cirrhosis (P=0.001).
  • H. pylori-infected patients showed significantly higher blood ammonia levels (129 vs. 112 μmol/l; P=0.002) and a higher prevalence of esophageal varices (60% vs. 14%; P<0.001).

Conclusions:

  • H. pylori infection is more prevalent in liver cirrhosis associated with viral hepatitis (postinflammatory) than in alcoholic or primary biliary cirrhosis.
  • H. pylori infection is significantly associated with elevated blood ammonia levels and the presence of esophageal varices in liver cirrhosis patients.
Abstract

Related Concept Videos

Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy01:16

Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy

Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...
1.6K
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies01:28

Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies

Peptic ulcer disease (PUD) presents with diverse symptoms depending on the location and severity of the ulcer. Clinical manifestations of peptic ulcer include dull pain and a burning sensation in the mid-epigastric region.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
695
Esophageal Varices-II: Clinical Features and Management01:28

Esophageal Varices-II: Clinical Features and Management

Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
685
Gastritis-II: Pathophysiology01:17

Gastritis-II: Pathophysiology

Gastritis is marked by disruption of the mucosal barrier that usually protects the stomach tissue from digestive juices and manifests in acute and chronic forms.
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
1.5K
Gastritis III: Clinical Manifestations and Management01:23

Gastritis III: Clinical Manifestations and Management

The clinical manifestations of gastritis can vary depending on the cause and type of gastritis, but some common symptoms may include the following.
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
1.4K
Diseases of the Liver and Gallbladder01:26

Diseases of the Liver and Gallbladder

Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
2.1K